Benchamin Abraham

Benchamin Abraham

Auto-generated profile, based on publicly available information

Benchamin Abraham

IISER Pune

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Chemistry – A European Journal
Verified
Journal Article
Closed access
NRNaveen J. Roy
Naveen J. Roy
SSShreyada N. Save
Shreyada N. Save
VSVirender Kumar Sharma
Virender Kumar Sharma
BABenchamin Abraham
Benchamin Abraham
AKAbhijith Kuttanamkuzhi
Abhijith Kuttanamkuzhi
PTPinaki Talukdar
Pinaki Talukdar

25 June 2026 in bioRxiv
Verified
Preprint
Open access
BABenchamin Abraham
Benchamin Abraham
AUAyushi Upadhyay
Ayushi Upadhyay
KMKhushi Malhotra
Khushi Malhotra
AMAjay J Malik
Ajay J Malik
DVDhananjay Virkar
Dhananjay Virkar
MLMayurika Lahiri
Mayurika Lahiri
Api5 is elevated in a number of cancers and is associated with many hallmarks of cancer, including resistance to apoptosis, immune escape, stemness, chemotherapy resistance, high proliferation, and cell-cycle dysregulation. In this study, we identified the DNA and chromatin-binding activities of Api5 in tumorigenic cells, as well as its association with genomic instability and chemotherapy resistance. Knockdown of Api5 resulted in reduced nuclear volume, DNA content, and chromosome number, and increased sensitivity to DNA damage. The survival of Api5-knockdown cells decreased following UV and cisplatin treatments due to the accumulation of damaged DNA and inefficient nucleotide excision repair. Interestingly, Api5 knockdown cells also exhibited low pChk1 levels following UV damage. Further, we confirmed the chemotherapy resistance phenotype in cancers with elevated Api5 levels, demonstrating that xenograft tumours with Api5 knockdown responded better to cisplatin, with significant tumour regression.